| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 From the Departments of Biomolecular Recognition and Ophthalmology and 2 Ocular Pathophysiology, Yamaguchi University School of Medicine, Ube City, Yamaguchi, Japan.
PURPOSE. To characterize the intracellular signaling mechanism that underlies the contraction of trabecular meshwork (TM) tissue.
METHODS. The contraction of collagen mediated by bovine TM cells was evaluated by measuring changes in the diameter of collagen gels in which the cells were embedded. Changes in the organization of the actin cytoskeleton were examined by laser-scanning confocal microscopy of cells stained with fluorescent phalloidin. Cell motility was monitored by time-lapse video microscopy.
RESULTS. Transforming growth factor (TGF)-ß1 induced marked TM-cell–mediated contraction of collagen gels in a concentration- and time-dependent manner. Inhibitors of protein kinase C (PKC) blocked this effect of TGF-ß1, whereas an inhibitor of PKA and -G did not. An inhibitor of the small guanosine triphosphatase (GTPase) Rho also inhibited TGF-ß1–induced collagen contraction, whereas an activator of Rho promoted this effect of TGF-ß1. Furthermore, inhibition either of the release of Ca2+ from internal stores or of the activation of myosin light-chain kinase (MLCK) prevented gel contraction in response to TGF-ß1. The effects of these various agents on TGF-ß1–induced contraction of collagen gels mediated by TM cells were mirrored by their effects on TGF-ß1–induced formation of actin stress fibers, cell spreading (the extension of cellular processes), and cell motility under conditions in which cell contraction was not possible.
CONCLUSIONS. TGF-ß1 induces TM-cell–mediated collagen gel contraction through activation of Rho and the Ca2+-dependent enzymes PKC and MLCK. These same signaling molecules contribute to TGF-ß1–induced rearrangement of the actin cytoskeleton, cell spreading, and cell motility.
This article has been cited by other articles:
|
|
 |
|
  M. Honjo, H. Tanihara, T. Kameda, T. Kawaji, N. Yoshimura, and M. Araie Potential Role of Rho-Associated Protein Kinase Inhibitor Y-27632 in Glaucoma Filtration Surgery Invest. Ophthalmol. Vis. Sci., December 1, 2007; 48(12): 5549 - 5557. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Tamimi, J. M. Skarie, T. Footz, F. B. Berry, B. A. Link, and M. A. Walter FGF19 is a target for FOXC1 regulation in ciliary body-derived cells Hum. Mol. Genet., November 1, 2006; 15(21): 3229 - 3240. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. G. Docherty, O. E. O'Sullivan, D. A. Healy, M. Murphy, A. J. O'Neill, J. M. Fitzpatrick, and R. W. G. Watson TGF-beta1-induced EMT can occur independently of its proapoptotic effects and is aided by EGF receptor activation Am J Physiol Renal Physiol, May 1, 2006; 290(5): F1202 - F1212. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Meyer-ter-Vehn, S. Gebhardt, W. Sebald, M. Buttmann, F. Grehn, G. Schlunck, and P. Knaus p38 Inhibitors Prevent TGF-{beta}-Induced Myofibroblast Transdifferentiation in Human Tenon Fibroblasts. Invest. Ophthalmol. Vis. Sci., April 1, 2006; 47(4): 1500 - 1509. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Cairns, I. Papandreou, and N. Denko Overcoming Physiologic Barriers to Cancer Treatment by Molecularly Targeting the Tumor Microenvironment Mol. Cancer Res., February 1, 2006; 4(2): 61 - 70. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Nakamura, T. Sagara, K. Seki, S. Hirano, and T. Nishida Permissive Effect of Fibronectin on Collagen Gel Contraction Mediated by Bovine Trabecular Meshwork Cells Invest. Ophthalmol. Vis. Sci., October 1, 2003; 44(10): 4331 - 4336. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
